Presentation

Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting BiOSS LIM® Stent In Coronary Bifurcation Treatment ? Randomized POLBOS II Study_

Presenter: Jacek Bil

September 16, 2014

REGISTER for free or LOG IN to view this content

Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting BiOSS LIM® Stent In Coronary Bifurcation Treatment ? Randomized POLBOS II Study_

Coronary

Presentation

TCT 2014

Up Next

Presentation

Long-term 25 Years Follow-up of Mitral Valvuloplasty with Single Balloon_ Independent Predictors of Survival and Event Free Survival

Presenter: Edison Peixoto

September 16, 2014

More slides +

Presentation

Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: A Report from NCDR

Presenter: Emmanouil Brilakis

September 16, 2014

Presentation

First Percutaneous Transluminal Caval flow Restriction in a Patient with Congestive Heart Failure_

Presenter: Jose Herrera

September 16, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.